Q32 Bio

Q32 Bio

  • Founded: 2017
  • Location: Cambridge, MA
  • Employee range: 11 - 50
  • Clinical stage: Clin2
  • Therapy area: Atopic dermatitis
  • Drug types: DRM, IMM
  • Lead product: ADX-914 (partner: Horizon)
  • Product link: https://www.q32bio.com/our-pipeline/
  • Funding: $60M B Oct 2020; $46M A May 2020



job board

Short description:

Biologics to restore healthy immune regulation

Drug notes:

ADX-097 Clin1 complement driven disorders; 2 undisclosed programs RD/Clin0 complement driven disorders

Long description:

Contact us to add description: recruit@workinbiotech.com


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com